Antioxidant effects of Epicatechin on the hippocampal toxicity caused by Amyloid-beta 25-35 in rats

European Journal of Pharmacology

Volumn 616, Issue 1-3, 2009, Pages 122-127

  Cuevas, Elvis ^a   Limón, Daniel ^b   Pérez Severiano, Francisca ^a   Díaz, Alfonso ^a,b   Ortega, Laura ^b   Zenteno, Edgar ^c,d   Guevara, Jorge ^c  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d UNIVERSIDAD RICARDO PALMA   (Peru)

Author keywords

Alzheimer's disease; Amyloid beta; Epicatechin; Flavonoid; Memory; Oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; EPICATECHIN; GLIAL FIBRILLARY ACIDIC PROTEIN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN DAMAGE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HIPPOCAMPUS; LEARNING; LIPID PEROXIDATION; MALE; MEMORY; MENTAL TASK; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; SKILL;

AMYLOID BETA-PROTEIN; ANIMALS; ANTIOXIDANTS; CATECHIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; MAZE LEARNING; MEMORY; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES;

EID: 67749107941     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.06.013     Document Type: Article

References (59)

1. Ali S.F., David S.N., and Newport G.D. Age-related susceptibility to MPTP-induced neurotoxicity in mice. Neurotoxicology 14 (1993) 29-34
2. Baba S., Osakabe N., Natsume M., Muto Y., Takizawa T., and Terao J. In vivo comparison of the bioavailability of (+)-catechin, (-)-epicatechin and their mixture in orally administered rats. J. Nutr. 131 (2001) 2885-2891
3. Ban J.Y., Cho S.O., Koh S.B., Song K.S., Bae K., and Seong Y.H. Protection of amyloid beta protein (25-35)-induced neurotoxicity by methanol extract of Smilacis chinae rhizome in cultured rat cortical neurons. J. Ethnopharmacol. 106 (2006) 230-237
4. Ban J.Y., Jeon S.Y., Bae K., Song K.S., and Seong Y.H. Catechin and epicatechin from Smilacis chinae rhizome protect cultured rat cortical neurons against amyloid beta protein (25-35)-induced neurotoxicity through inhibition of cytosolic calcium elevation. Life Sci. 79 (2006) 2251-2259
5. Barnham K.J., Masters C.L., and Bush A.I. Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 3 (2004) 205-214
6. Bastianetto S., and Quirion R. Natural extracts as possible protective agents of brain aging. Neurobiol. Aging 23 (2002) 891-897
7. Bastianetto S., Yao Z.X., Papadopoulos V., and Quirion R. Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity. Eur. J. Neurosci. 23 (2006) 55-64
8. Bastianetto S., Krantic S., and Quirion R. Polyhenols as potential inhibitors of amyloid aggregation and toxicity: possible significance to Alzheimer's disease. Min. Rev. Med. Chem. 8 (2008) 429-435
9. Butterfield D.A., and Kanski J. Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid ß-peptide 1-42. Peptides 23 (2001) 1299-1309
10. Butterfield D.A., Castegna A., Lauderback C.M., and Drake J. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol. Aging 23 (2002) 655-664
11. Cão G., Sofic E., and Prior R. Antioxidant and prooxidant behavior of flavonoids structure-activity relationships. Free Radic. Biol. Med. 22 (1997) 749-760
12. Choi Y.T., Jung C.H., Lee S.R., Bae J.H., Baek W.K., Suh M.H., Park J., Park C.W., and Suh S.I. The green tea polyphenol (-)-epigallocatechin gallate attenuates beta-amyloid-induced neurotoxicity in cultured hippocampal neurons. Life Sci. 70 (2001) 603-614
13. Conte A., Pellegrini S., and Tagliazucchi D. Synergistic protection of PC12 cells from beta-amyloid toxicity by resveratrol and catechin. Brain Res. Bull. 62 (2003) 29-38
14. Da Silva E.L., Piskula M., and Terao J. Enhancement of antioxidative ability of rat plasma by oral administration of (-)-epicatechin. Free Radic. Biol. Med. 24 (1998) 1209-1216
15. Delobette S., Privat A., and Maurice T. In vitro aggregation facilitates beta-amyloid peptide-(25-35)-induced amnesia in the rat. Eur. J. Pharmacol. 319 (1997) 1-4
16. Drouet B., Pinçon-Raymond M., Chambaz J., and Pillot T. Molecular basis of Alzheimer's disease. Cell. Mol. Life Sci. 57 (2000) 705-715
17. Haque A.M., Hashimoto M., Katakura M., Tanabe Y., Hara Y., and Shido O. Long-term administration of green tea catechins improves spatial cognition learning ability in rats. J. Nutr. 136 (2006) 1043-1047
18. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 298 (2002) 962-964
19. Heo H.J., and Lee C.Y. Epicatechin and catechin in cocoa inhibit amyloid beta protein induced apoptosis. J. Agric. Food Chem. 53 (2005) 1445-1448
20. Iqbal K., Flory M., Khatoon S., Soininen H., Pirttila T., Lehtovirta M., Alafuzoff I., Blennow K., Andreasen N., Vanmechelen E., and Grundke-Iqbal I. Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers. Ann. Neurol. 58 (2005) 748-757
21. Ishige K., Schubert D., and Sagara Y. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic. Biol. Med. 30 (2001) 433-446
22. Kostyuk V.A., Potapovich A.I., Strigunova E.N., Kostyuk T.V., and Afanas'ev I.B. Experimental evidence that flavonoid metal complexes may act as mimics of superoxide dismutase. Arch. Biochem. Biophys. 428 (2004) 204-208
23. Lee S.Y., Lee J.W., Lee H., Yoo H.S., Yun Y.P., Oh K.W., Ha T.Y., and Hong J.T. Inhibitory effect of green tea extract on beta-amyloid-induced PC12 cell death by inhibition of the activation of NF-kappaB and ERK/p38 MAP kinase pathway through antioxidant mechanisms. Brain Res. Mol. Brain Res. 140 (2005) 45-54
24. Levites Y., Amit T., Mandel S., and Youdim M.B. Neuroprotection and neurorescue against A-beta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate. FASEB J. 17 (2003) 952-954
25. Limón I.D., Díaz A., Mendieta L., Chamorro G., Espinosa B., Zenteno E., and Guevara J. Amyloid-beta(25-35) impairs memory and increases NO in the temporal cortex of rats. Neurosci. Res. 63 (2009) 129-137
26. Limón I.D., Mendieta L., Díaz A., Chamorro G., Espinosa B., Zenteno E., and Guevara J. Neuroprotective effect of alpha-asarone on spatial memory and nitric oxide levels in rats injected with amyloid-beta(25-35). Neurosci. Lett. 453 (2009) 98-103
27. Longpré F., Garneau P., Christen Y., and Ramassamy C. Protection by EGb 761 against beta-amyloid-induced neurotoxicity: involvement of NF-kappaB, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formation. Free Radic. Biol. Med. 41 (2006) 1781-1794
28. Luximon-Ramma A., Bahorun T., Crozier A., Zbarsky V., Datla K., Dexter D., and Aruoma O. Characterization of the antioxidant functions of flavonoids and proanthocyanidins in Mauritian black teas. Food Res. Int. 38 (2005) 357-367
29. Mandel S., and Youdim M.B. Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radic. Biol. Med. 37 (2004) 304-317
30. Mandel S., Weinreb O., Amit T., and Youdim M.B. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases. J. Neurochem. 88 (2004) 1555-1569
31. Marambaud P., Zhao H., and Davies P. Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J. Biol. Chem. 280 (2005) 37377-37382
32. Mattson M.P. Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimer's disease. J. Neurovirol. 8 (2002) 539-550
33. Maurice T., Lockhart B.P., and Privat A. Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction. Brain Res. 706 (1996) 181-193
34. McGeer P.L., and McGeer E.G. Local neuroinflammation and the progression of Alzheimer's disease. J. Neurovirol. 8 (2002) 529-538
35. Mohsen M.A., Marks J., Kuhnle G., Rice-Evans C., Moore K., Gibson G., Debnam E., and Srai S.K. The differential tissue distribution of the citrus flavanone naringenin following gastric instillation. Free Radic. Res. 38 (2004) 1329-1340
36. Moreira P.I., Nunomura A., Nakamura M., Takeda A., Shenk J.C., Aliev G., Smith M.A., and Perry G. Nucleic acid oxidation in Alzheimer disease. Free Radic. Biol. Med. 44 (2008) 1493-1505
37. Olton D.S. Spatial memory. Sci. Am. 236 (1977) 82-84 89-94; 96; 98
38. Orgogozo J.M., Dartigues J.F., Lafont S., Letenneur L., Commenges D., Salamon R., Renaud S., and Breteler M.B. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev. Neurol. (Paris) 153 (1997) 185-192
39. Pan T., Fei J., Zhou X., Jankovic J., and Le W. Effects of green tea polyphenols on dopamine uptake and on MPP+-induced dopamine neuron injury. Life Sci. 72 (2003) 1073-1083
40. Parihar M.S., and Hemnani T. Alzheimer's disease pathogenesis and therapeutic interventions. J. Clin. Neurosci. 11 (2004) 456-467
41. Paxinos G., and Watson C. Hippocampal fissure. In: Paxinos G., and Watson C. (Eds). The Rat Brain in Stereotaxic Coordinates (1997), Academic Press 30-46
42. Pérez-Severiano F., Salvatierra S.R., Rodríguez P.M., Cuevas M.E., Guevara J., Limon D., Maldonado D.P., Medina C.O., Pedraza C.J., and Santamaría A. S-allylcysteine prevents amyloid-ß peptide-induced oxidative stress in rat hippocampus and ameliorates learning deficits. Eur. J. Pharmacol. 489 (2004) 197-202
43. Pike C.J., Walencewicz-Wasserman A.J., Kosmoski J., Cribbs D.H., Glabe C.G., and Cotman C.W. Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J. Neurochem. 64 (1995) 253-265
44. Piskula M.K., and Terao J. Accumulation of (-)-epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues. J. Nutr. 128 (1998) 1172-1178
45. Probst A., Herzig M.C., Mistl C., Ipsen S., and Tolnay M. Perisomatic granules (non-plaque dystrophic dendrites) of hippocampal CA1 neurons in Alzheimer's disease and Pick's disease: a lesion distinct from granulovacuolar degeneration. Acta Neuropathol. 102 (2001) 636-644
46. Rezai-Zadeh K., Shytle D., Sun N., Mori T., Hou H., Jeanniton D., Ehrhart J., Townsend K., Zeng J., Morgan D., Hardy J., Town T., and Tan J. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J. Neurosci. 25 (2005) 8807-8814
47. Saez T.E., Pehar M., Vargas M., Barbeito L., and Maccioni R.B. Astrocytic nitric oxide triggers tau hyperphosphorylation in hippocampal neurons. In Vivo 18 (2004) 275-280
48. Selkoe D.J. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann. N.Y. Acad. Sci. 924 (2000) 17-25
49. Spencer J.P., Schroeter H., Crossthwaithe A.J., Kuhnle G., Williams R.J., and Rice-Evans C. Contrasting influences of glucuronidation and O-methylation of epicatechin on hydrogen peroxide-induced cell death in neurons and fibroblasts. Free Radic. Biol. Med. 31 (2001) 1139-1146
50. Stepanichev M.Y., Zdobnova I.M., Zarubenko I.I., Moiseeva Y.V., Lazareva N.A., Onufriev M.V., and Gulyaeva N.V. Amyloid-beta(25-35)-induced memory impairments correlate with cell loss in rat hippocampus. Physiol. Behav. 80 (2004) 647-655
51. Storey E., Kinsella G.J., and Slavin M.J. The neuropsychological diagnosis of Alzheimer's disease. J. Alzheimer's Dis. 3 (2001) 261-285
52. Tomidokoro Y., Ishiguro K., Harigaya Y., Matsubara E., Ikeda M., Park J.M., Yasutake K., Kawarabayashi T., Okamoto K., and Shoji M. Abeta amyloidosis induces the initial stage of tau accumulation in APP(Sw) mice. Neurosci. Lett. 299 (2001) 169-172
53. Vajda F.J. Neuroprotection and neurodegenerative disease. J. Clin. Neurosci. 9 (2002) 4-8
54. Williams R.J., Spencer J.P., and Rice-Evans C. Flavonoids: antioxidants or signalling molecules?. Free Radic. Biol. Med. 36 (2004) 838-849
55. Wisniewski H.M., Wegiel J., and Kotula L. Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines. Neuropathol. Appl. Neurobiol. 22 (1996) 3-11
56. Wyss-Coray T., and Mucke L. Inflammation in neurodegenerative disease-a double-edged sword. Neuron 35 (2002) 419-432
57. Yankner B.A. Amyloid and Alzheimer's disease cause or effect?. Neurobiol. Aging 10 (1989) 470-471
58. Youdim K.A., Shukitt-Hale B., and Joseph J.A. Flavonoids and the brain: interactions at the blood-brain barrier and their physiological effects on the central nervous system. Free Radic. Biol. Med. 37 (2004) 1683-1693
59. Zheng H., Xu H., Uljon S.N., Gross R., Hardy K., Gaynor J., Lafrancois J., Simpkins J., Refolo L.M., Petanceska S., Wang R., and Duff K. Modulation of A(beta) peptides by estrogen in mouse models. J. Neurochem. 80 (2002) 191-196